News | November 26, 2022
Delivery solution provider ZIM Laboratories Limited lists on NSE
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Ayush market has reached US $18 billion from meager US $3 billion under guidance and visionary leadership of our Prime Minister
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market
The company sees the business reaching $100mn
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
Subscribe To Our Newsletter & Stay Updated
